Highlights d Id1 acts as a ''sensor'' to detect when cells lack both Nanog and Nodal activity 
INTRODUCTION
Pluripotent cells in the early embryo choose their fate according to the signals they receive from their local environment (Arnold and Robertson, 2009 ). However, pluripotent cells are unlikely to respond passively to prevailing signals. Rather, the ability to respond to or ignore particular signals must be tightly coordinated with changes in differentiation potential in order to ensure that cell fate decisions are not misdirected by premature fluctuations in pro-differentiation cues.
Control over signal responsiveness becomes particularly important where the same signal is re-deployed to regulate successive cell fate restrictions. For example, fibroblast growth factor (FGF) drives naive pluripotent cells in the early embryo to differentiate into extraembryonic cell types (Chazaud et al., 2006; Hamilton and Brickman, 2014; ; Yamanaka et al., 2010), whereas FGF helps to sustain pluripotency once pluripotent cells have transitioned into a ''primed'' state (Arnold and Robertson, 2009; Brons et al., 2007; Tesar et al., 2007) . Therefore, for this transition to proceed successfully, the shift in FGF activity must somehow be timed to occur only after cells irreversibly commit to the primed epiblast state.
Nodal protects pluripotency in the primed epiblast of the postimplantation embryo (Camus et al., 2006; Mesnard et al., 2006) while Nanog protects pluripotency in the naive epiblast of the pre-implantation embryo (Mitsui et al., 2003) . The handover between these two factors does not, however, appear to proceed seamlessly: some Nanog-negative epiblast cells lack Nodal activity in the late pre-implantation embryo (Granier et al., 2011) . With neither Nanog nor Nodal available to sustain epiblast identity, these transiting epiblast cells would be in a precarious state, unless some other factor comes into play to protect them against the pro-endoderm effects of autocrine FGF (Chazaud et al., 2006; Hamilton and Brickman, 2014; Yamanaka et al., 2010) . This putative factor should have three key properties: the ability to sense low levels of Nodal activity, the ability to dampen FGF responsiveness, and the ability to protect pluripotent cells from differentiation.
A likely candidate is the BMP (Bone Morphogenic Protein) target gene Id1. Id1 is sensitive to Nodal activity (Galvin et al., 2010) and is able to prevent differentiation of pluripotent cells Zhang et al., 2010) , but the details of when and how it operates remain unclear. It has been proposed that Id1 supports naive pluripotency by maintaining high levels of Nanog (Galvin-Burgess et al., 2013; Romero-Lanman et al., 2012; . However, surprisingly, we report here that Id1 protein is absent from the embryonic day (E) 3.5 embryo and is only expressed in cells that have lost Nanog expression during peri-implantation development. This seems incompatible with the idea that BMP-Id1 maintains naive pluripotency but is consistent with idea that Id1 comes into play to protect epiblast identity after downregulation of Nanog.
Here, we report that Id1 stabilizes an epiblast identity specifically during the transition between naive and primed states. Id1 acts as a ''sensor'' to detect when cells have lost Nanog expression but have not yet acquired Nodal activity. Id1 then suppresses FGF in order to protect these cells from aberrant differentiation. Once a Nodal-responsive post-implantation epiblast state has been achieved, Nodal suppresses Id1 expression and so permits FGF activity to rise to help sustain pluripotency in newly configured primed epiblast cells. We propose that this mechanism helps to coordinate changes in extrinsic and intrinsic information to ensure a robust transition through peri-implantation development.
RESULTS

Pluripotent Cells Remain Resistant to BMP Signaling until Peri-implantation Development
We examined whether pluripotent cells modulate responsiveness to prevailing signals as they proceed toward differentiation. We focused on BMP signaling because BMP suppresses differentiation of pluripotent cells in culture and in vivo (Di-Gregorio et al., 2007) . The BMP target gene Id1 (Hollnagel et al., 1999) recapitulates the effects of BMP on pluripotent cells Zhang et al., 2010) and provides a biologically relevant readout of BMP activity (Figures S1A-S1C).
Bmp4/7 and pSmad1 are readily detectable in pre-implantation embryos at E3.5 (Coucouvanis and Martin, 1999; Graham et al., 2014) . However, to our surprise, we were unable to detect the product of the direct BMP target gene Id1 in E3.5 embryos ( Figure 1A ) or in early E4.5 embryos (data not shown). We then examined embryos after E4.5, at the latest stage obtainable before the embryo implants. These embryos contain a subpopulation of Id1+ cells scattered throughout the epiblast in a salt-and-pepper distribution ( Figure 1B ). This suggests that patterning of Id1 is unlikely to be explained only by exposure to exogenous BMP ligands (because these ligands are diffusible and so unlikely to adopt a salt-and-pepper distribution) and instead might reflect cell-cell variability in BMP responsiveness.
In order to test this, we examined pluripotent cells in culture, where we could stimulate cells with BMP4. We first examined cells in 2i + LIF culture, which supports a stage of pluripotency equivalent to that of the early E4.5 blastocyst (Boroviak et al., 2015) . We were unable to detect Id1 protein even after stimulating 2i + LIF cells with high doses (10 ng/mL) of BMP4 (Figure 1C) . These findings were confirmed using cells in which an Id1-Venus fusion was expressed from the Id1 locus (Figures 1D and S1D-S1G) Nam and Benezra, 2009 ).
We then examined embryonic stem cells (ESCs) in LIF (leukemia inhibitory factor) + fetal calf serum (FCS), a culture condition that supports a mixture of naive and primed cells ). We could detect Id1 protein in some cells, although a subpopulation remained Id1 negative even when stimulated with BMP4 ( Figures 1E and 1F ), in keeping with reports that naive cells do not activate Id1 in response to BMP (Gomes Fernandes et al., 2016) .
We then examined post-implantation embryos and epiblast stem cells (EpiSCs) (Brons et al., 2007; Tesar et al., 2007) . As expected, the E5.5 epiblast expresses Id1 in cells close to the extraembryonic ectoderm, a source of BMP signals (Arnold and Robertson, 2009) (Figures 1G and S1H ). EpiSC stimulated with BMP4 express moderate levels of Id1 in a minor subset of cells ( Figures 1H and 1I ), indicating that BMP responsiveness decreases as pluripotent cells reach a primed state. This transient window of Id1 expression at the onset of the transition between naive and primed pluripotency can be recapitulated in vitro in epiblast-like cell (EpiLC) differentiation ( Figure S1J ).
Some epiblast cells in the late E4.5 embryo downregulate the naive determinant Nanog to prepare for the transition to a primed state (Xenopoulos et al., 2015) . We detect Id1 exclusively within these Nanog-low cells ( Figure 1B) . Similarly, Id1 is expressed predominantly in Nanog-low cells in LIF + FCS ( Figures 1J  and 1K) .
We conclude that pluripotent cells modulate responsiveness to BMP4 over time. They become most responsive as they enter a transition phase between naive and primed pluripotency, corresponding to a stage of peri-implantation development after downregulation of Nanog but before establishment of a primed pluripotent state ( Figure 1L ).
Id1 Predicts the Probability of Differentiating after Downregulation of Nanog
It is surprising that Id1, which maintains pluripotency of ESCs Zhang et al., 2010) , is not expressed in Nanog-high cells in vivo or in culture ( Figures 1B, 1J , and 1K). Could it instead be protecting epiblast identity during the transition from naive to primed states?
The transition to a primed state is initiated by downregulation of Nanog in concert with other components of the naive gene regulatory network (GRN) (Kalkan et al., 2017) . However, loss of Nanog does not commit cells to undergo this transition: some Nanog-low cells resist differentiation and revert back to a Nanog-high state (Chambers et al., 2007; Kalmar et al., 2009) . We asked whether Id1 identifies those cells that resist differentiation after loss of Nanog.
We generated a dual-reporter ESC line, which expresses an Id1-Venus fusion protein from the endogenous Id1 locus Nam and Benezra, 2009) , and a Nanog-tagRFP fusion protein from the endogenous Nanog locus . We first confirmed that Nanog and Id1 tend to mark different subpopulations in LIF + FCS ( Figure 2B ). We then sorted three populations of cells from LIF + FCS: Nanog-high (NR-HI IdV-LO), Id1-high Nanog-low (IdV-HI NR-LO), and Id1-low Nanog-low cells (IdV-LO NR-LO) ( Figures 2C and S2F ).
As expected (Festuccia et al., 2012) , transcriptomes differed between Nanog-high cells and Nanog-low cells. In contrast, within the Nanog-low compartment, transcriptomes of Id1-high and Id1-low cells were almost indistinguishable (Figures 2D  and 2E ; Table S1 ).
Id1 is not a transcriptional regulator: it acts by controlling the activity of a range of proteins (Norton, 2000; Roberts et al., 2001; Yates et al., 1999) , so it seemed plausible that Id1-high cells may be more resistant to differentiation than Id1-low cells despite their similar transcriptomes. We tested the sorted subpopulations for resistance to differentiation. We challenged cells with differentiation medium (N2B27) for 6 h and then returned them to self-renewal conditions at clonal density to assess how many cells remained undifferentiated. We also plated sorted cells directly into selfrenewal conditions at clonal density to measure the number of undifferentiated cells in each starting population. We combined these data to establish the proportion of undifferentiated cells that resist differentiation during the 6 h challenge ( Figure 2F ).
This reveals that Id1-high cells resist differentiation more effectively than Id1-low cells: the majority (62% ± 6%) of IdV-HI NR-LO cells resisted differentiation, as did the majority (69% ± 15%) of NR-HI IdV-LO cells. Only a minority (39% ± 5%) of IdV-LO NR-LO cells were able to resist differentiation ( Figure 2G ).
Although there is low residual expression of Nanog and other naive pluripotency transcription factors within our ''Nanog-low'' sorted subpopulations (Figures S2F and S2G) , this cannot explain our findings because there was no difference in expression of these factors between Id1-high and Id1-low cells (Figures S2G and S2H) , nor was there any difference in the number of colony-forming cells prior to the differentiation challenge (Figure S2I) , indicating that there are no functional differences in naive transcription factor activity between the two populations.
We conclude that Id1 identifies a subpopulation of Nanog-low cells that resist differentiation independently of the activity of the naive pluripotency GRN.
Id1 Protects Pluripotent Cells from Differentiation in the Absence of Nanog
Having seen that Id1 correlates with resistance to differentiation after downregulation of Nanog, we asked whether Id1 is capable of suppressing differentiation after downregulation of Nanog. We made use of an ESC line containing a doxycycline-inducible Id1 transgene . We placed these cells in N2B27 for 24 h, a time frame that is sufficient to downregulate members of the naive GRN (Kalkan et al., 2017) , in the presence or absence of doxycycline. We then replated the cells clonally in self-renewal conditions ( Figure 2H ). We find that forced expression of Id1 during this time window in which the naive GRN is dismantled increases the number of cells that resist differentiation ( Figure 2I ).
If Id1 protects pluripotent cells from differentiation in the absence of Nanog, then it should be able to rescue the spontaneous differentiation phenotype of Nanog-null cells in LIF + FCS (Chambers et al., 2007) . Forced expression of Id1 restores the colony-forming ability of Nanog-null cells to a similar extent to forced expression of Nanog itself ( Figures 2J and 2K ) and reduces the expression of markers of primitive endoderm (Gata4, Gata6, and Sox17) and primed epiblast (Fgf5 and Oct6, also known as Pou3f1) (Figures 2L and 2M) .
These data suggest that Id1 is responsible for protecting pluripotent cells from differentiation after downregulation of Nanog.
A Coordinated Shift in BMP and FGF and Nodal Responsiveness after Downregulation of Nanog
We looked for transcriptional changes that might explain why IdV-LO NR-LO cells are more susceptible to differentiation than IdV-HI NR-LO cells.
Compared with IdV-HI NR-LO cells, only six protein-coding genes were enriched in IdV-LO NR-LO cells (Figures 3A and 3B) . Only two of these, Egr1 and Lefty1, were confirmed by qRT-PCR to be differentially expressed ( Figures 3C and S3A ). Egr1 and Lefty1 are readouts of the FGF and Nodal signaling pathways, respectively, and these are the two pathways that sustain pluripotency in primed pluripotent cells (Brons et al., 2007; Camus et al., 2006; Tesar et al., 2007) . We confirmed (F) Experimental strategy. Id1-Venus Nanog-tagRFP ESCs cultured in LIF + FCS were sorted into three subpopulations then assayed for their ability to form AP+ colonies when plated at clonal density immediately after sorting and after 6-h N2B27 culture. (G) Proportion of cells capable of resisting differentiation after 6-h N2B27 culture. Number of AP+ colonies obtained after replating 6-h N2B27 cultures in LIF + FCS, divided by number of AP+ colonies obtained after replating cells in LIF + FCS immediately after sorting. Plating density: 1,000 cells/9 cm dish. Data are represented as mean ± SEM of three independent experiments. (H) Experimental strategy for Id1 gain-of-function experiment. ESCs carrying a doxycycline-inducible Id1 transgene were transferred from LIF + FCS culture to N2B27 for 24 h, in the presence or absence of 1mg/mL doxycycline. The cells were assayed for their ability to form AP+ colonies when replated at clonal density in LIF + FCS. (I) Number of AP+ colonies obtained after replating cells as described in (H). Plating density: 100 cells/well of a 6-well plate. Data are represented as mean ± SEM of five independent experiments. (J) Diagram of rescue of Nanog À⁄À cells. Clonal cell lines were generated to stably express Nanog (positive control), Id1, or GFP (negative control). Figure S2 and Table S1 . that the related FGF target gene Egr2, although not the related Nodal target gene Lefty2, is also enriched in IdV-LO NR-LO cells ( Figure 3C ). Id1 rescue of Nanog-null cells also correlates with reduced expression of Egr1 ( Figure S3B ). The FGF target gene Egr1 (although not the Nodal targets genes Lefty1 or Lefty2) remained enriched in Id1-low cells after a 6 h challenge with differentiation media, which is the time at which Id1-high cells display their relative resistance to differentiation ( Figure 3D ). Intriguingly, we do not observe differences in expression of naive or primed pluripotency markers between IdV-LO NR-LO and IdV-HI NR-LO cells at this time point ( Figures  S3C and S3D ), suggesting that differences in FGF sensitivity and response can predict resistance to differentiation prior to overt changes in pluripotency marker expression.
Having observed an increase in FGF target gene expression in IdV-LO NR-LO cells, we next asked whether these cells are more responsive to acute stimulation with exogenous Fgf2 than Id1-high cells ( Figure 3E ). We find that a higher proportion of IdV-LO NR-LO cells respond to Fgf2 stimulation by phosphorylating Erk1/2 (a direct readout of FGF activity) than Id1-high or Nanog-high cells (Figures 3F and 3G) .
These data suggest that there is a coordinated shift in signal responsiveness within the Nanog-low compartment, with cells becoming more responsive to FGF and Nodal signaling, as they lose Id1 expression. It is the increase in FGF responsiveness that best correlates with a higher probability of differentiating (model shown in Figure 3H ).
Id1 Is Responsible for Suppressing Differentiation within the Nanog-Low Compartment
We next asked how differentiation is suppressed within Id1-high cells. Eight genes are enriched in Id1-high cells ( Figure S4 ), including Id1 itself. Id1 has previously been reported to block differentiation of naive and primed pluripotent cells (Aloia et al., 2015; Malaguti et al., 2013; Romero-Lanman et al., 2012; Zhang et al., 2010) , but a role during the transition between these two states has not been explored.
Id1-null ESCs have impaired clonogenic potential and display reduced levels of Nanog and increased levels of the primed pluripotency marker Oct6 (Figures 4A-4C ). These phenotypes can be rescued by placing cells into 2i + LIF culture conditions in order to maintain uniform high levels of Nanog ( Figures 4D-4F ) or by addition of a Mek inhibitor (PD0325901) to LIF + FCS cultures in order to suppress FGF activity (Figures 4G-4I) .
These data suggest that Id1 is dispensable within naive (Nanog-high) pluripotent cells but that it protects cells from differentiating after downregulation of Nanog.
Id1 Dampens FGF Responsiveness
We next asked whether Id1 is responsible for suppressing FGF activity. Id1-null cells display increased expression of the FGF target gene Egr1, and this can be reversed by restoring Id1 expression ( Figures 5A-5C ). Nodal activity is also dampened in Id1-high cells ( Figures 3B and 3C ), but Id1-null cells do not have increased expression of the Nodal target gene Lefty1 (Figure 5D) , suggesting that Nodal signaling may regulate, rather than be regulated by, Id1 expression.
Egr1 is not only a passive readout of FGF activity; it also mediates the effects of FGF on pluripotent cells (Galonska et al., 2015) . Egr1 is correlated with and controlled by Id1 in our experiments ( Figures 3B-3D , 5A-5C, and S3B), so we asked how Id1 regulates Egr1.
E2A homodimers directly regulate Egr1 in pro-B cells (Lin et al., 2010) , and E2A activity is repressed by Id1 (Massari and Murre, 2000) . We therefore first considered E2A as a likely candidate for mediating the effects of Id1 on Egr1. However, this does not seem to be the case: Egr1 does not respond to experimental activation of E2A homodimers in ESCs ( Figures  S5A and S5B) .
We have previously identified Tcf15 as an Id-regulated pro-differentiation factor in ESCs . Transcriptome analysis of Tcf15-responsive genes indicates that Tcf15 upregulates Egr1 . Using Tcf15-null cells, we find that Tcf15 is required for maximal Egr1 expression after downregulation of Nanog ( Figures 5E and 5F ). These data are consistent with the idea that Id1 suppresses Egr1 expression through suppression of Tcf15 activity.
Taken together, our data suggest that Id1 orchestrates a coordinated shift in growth factor responsiveness and differentiation. Statistical analyses of qRT-PCR and QIF data were performed using a one-way ANOVA followed by Tukey's multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001. Methods for statistical analysis of transcriptomic data are described in the STAR Methods section. NR, Nanog-tagRFP; IdV, Id1-Venus; HI, high; LO, low, Meki: Mek inhibitor (1 mM PD0325901); QIF, quantitative immunofluorescence; +ve, positive. See also Figure S3 and Table S1 . Id1 Acts As a ''Sensor'' of Nodal Activity We report above that there is a transient peak of Id1 protein expression during the transition from naive to primed epiblast states resulting from changes in ''responsiveness'' to BMP rather than changes in ''exposure'' to BMP ( Figures 1C-1F, 1H , and 1I). We asked what is responsible for suppressing Id1 in naive cells. Nanog is able to repress Id1 expression (Figures S6A and S6B ; Festuccia et al., 2012; Suzuki et al., 2006) and Id1 is derepressed in Nanog-null cells (Figures 6A and 6B) . We examined Nanognull ESCs in which the naive subpopulation can be identified via a fluorescent reporter targeted to the Nanog locus (Chambers et al., 2007) . This confirmed that there is an overall increase in Id1 expression, although Id1 remains repressed in a subset of Nanog-null cells (Figures 6C and 6D) . We conclude that Nanog contributes to, but is not solely responsible for, repression of Id1.
Nodal signaling is also able to repress Id1 expression (Galvin et al., 2010; Galvin-Burgess et al., 2013) . The Nodal target gene Lefty1 is enriched in Id1-low cells in LIF + FCS ( Figures  3B and 3C ) yet is not affected in Id1-null cells ( Figure 5D ), supporting the idea that Nodal signaling acts upstream rather than downstream of Id1.
In 2i + LIF, BMP4 is usually unable to upregulate Id1 ( Figures  1C and 1D ), but after addition of the Nodal inhibitor SB431542, almost all cells switch on Id1 in response to BMP4 ( Figures  6E-6G) . Similarly, in LIF + FCS cultures, SB431542 derepresses Id1, with the strongest increase observed within the Nanog-low subpopulation ( Figures 6H-6J ). SB431542 also permits BMP4-induced Id1 expression in EpiSCs (Figures 6K-6M ). In keeping with these observations, treatment of 2i + LIF and LIF + FCS cultures with the Nodal agonist Activin A inhibits Id1 induction by BMP4 ( Figures S6C and S6D ). These data suggest that Nodal is the primary factor responsible for dampening Id1 expression in primed cells.
We conclude that Nanog and Nodal repress Id1 within naive cells and that Nodal also dampens Id1 expression within primed cells. This explains how Id1 can act as a ''sensor'' of Nodal activity after downregulation of Nanog ( Figure 6N ).
Id1 Is Required for a Robust Transition from a Naive to a Primed Epiblast State In Vivo
Our findings suggest that Id1 protects epiblast cells from pro-differentiation cues from the time they lose Nanog expression through to the time that Nodal signaling begins to sustain them in a primed state.
In keeping with this model, Id1 is dispensable under optimized differentiation conditions in vitro, where inappropriate pro-differentiation signals are eliminated ( Figure S7A) . We predict that Id1 should become important under sup-optimal signaling conditions such as those in the peri-implantation embryo where, for example, Nodal becomes activated in only a subset of Nanoglow cells (Granier et al., 2011) . We devised an in vitro assay to mimic these conditions. We cultured pluripotent cells in basal media (N2B27) in order to allow cells to initiate exit from naive pluripotency in the absence of exogenous cues. After 48 h, we provided cells with low levels (1 ng/mL) of the Nodal agonist Activin A to approximate the incomplete activation of Nodal in vivo ( Figure 7A ). We used Oct4 (Pou5f1) to indicate the ability of these cells to retain an epiblast identity.
When this assay is carried out in the absence of BMP, only around half of cells retained Oct4 expression ( Figures 7B-7D and S7B: note bimodal distribution of Oct4 in Figures 7C and  S7B ). Exposing cells to BMP in order to activate Id1 during the first 48 h increased the robustness with which cells progress through this transition, with the majority of cells maintaining Oct4 expression (Figures 7B-7D and S7B: note unimodal distribution of Oct4 in Figures 7C and S7B) .
These results go some way toward supporting the hypothesis that BMP-Id1 helps to protect pluripotent cells from suboptimal signaling conditions. However, our in vitro assay falls far short of capturing the complexities of the dynamic signaling environment of the peri-implantation embryo. We therefore turned to an in vivo assay system. We examined the efficiency with which Id1-null cells can persist throughout implantation and contribute to the post-implantation epiblast in aggregation chimeras ( Figure 7E ). Cells, which differentiate aberrantly or activate FGF prematurely during this process, are eliminated by cell competition (Clavería et al., 2013; Díaz-Díaz et al., 2017; Sancho et al., 2013) .
Id1-null cells are able to contribute to the post-implantation epiblast: 57% of embryos contained at least some Id1-null ESCs, which is comparable to results from wild-type cells (67% of embryos) and Id1-rescue cells (54% of embryos) (Figures 7F and 7G) . However, the degree of contribution was lower for Id1-null cells (30% high contribution) than wild-type (74% high contribution) or Id1-rescue cells (53% high contribution) ( Figures 7F and 7G) . Quantifying the number of ESCs that contribute to the post-implantation epiblast confirmed that Id1-null cells contribute to the epiblast less robustly than wild-type or Id1-rescue cells (Figures 7F-7H ). All data are represented as mean ± standard deviation of three independent experiments. Statistical analyses were performed using a one-way ANOVA followed by Tukey's multiple comparison test. **p < 0.01. Plating density was 100 cells/well of a 6-well plate for clonal assays. Note that the height of the y axes differs between (A), (D), and (G). Immunofluorescence scale bars: 30 mm. See also Figure S4 .
In contrast, Id1-null ESCs contribute efficiently to the pre-implantation pluripotent epiblast, displaying no sign of premature differentiation or cell death (Figures S7C-S7E ). This confirms that Id1 is not required in naive pluripotent cells but becomes important during peri-implantation development.
We conclude that Id1 is required for a robust transition from the pre-implantation to the post-implantation epiblast in vivo. Data are presented as mean ± standard deviation of three independent experiments. Statistical analyses were performed using a one-way ANOVA followed by Tukey's multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S5 . (legend continued on next page) Galonska et al., 2015; Leeb et al., 2014; Yang et al., 2012) . Much less is known about how pluripotency is protected during the transition between these states. We propose that cells regulate changes in signal responsiveness in order to protect pluripotency during this transition and that Id1 coordinates this process.
In the absence of Id1, cells fail to transit robustly from preimplantation to post-implantation stages of development. Cells modulate signal responsiveness as they exit pluripotency (Kalkan et al., 2017; Zhou et al., 2013) and it has been proposed that prior to differentiation pluripotent cells enter a ''transition state'' or ''formative'' state in which they become more responsive to prevailing cues (Rué and Martinez Arias, 2015; Smith, 2017) , an idea that is supported by our findings.
How Are Cells Protected from Differentiation after the Collapse of the Naive GRN? In culture, ESCs do not commit to a primed state immediately after downregulating Nanog, but rather can reassemble a naive GRN and revert to naive pluripotency (Chambers et al., 2007; MacArthur et al., 2012) . A proportion of Nanog-low cells are nevertheless spontaneously lost to differentiation (Chambers et al., 2007) . Several lines of evidence suggest that the decision of Nanog-low cells to regain Nanog or to differentiate is stochastic (Abranches et al., 2014; Kalmar et al., 2009; MacArthur et al., 2012) . This might prompt the assumption that no particular factor is brought into play to determine the ability of cells to retain pluripotency and return to a Nanog-high state.
However, the following observations from peri-implantation embryos call this assumption into question: in peri-implantation embryos, in contrast to the situation in culture, cells that lose Nanog after E4.5 neither return to a Nanog-high naive state (Xenopoulos et al., 2015) nor differentiate into extraembryonic endoderm (Grabarek et al., 2012) . Rather, they are efficiently captured into a post-implantation epiblast state that is dependent on Nodal (Camus et al., 2006; Mesnard et al., 2006) . The existence of cells in the embryo that lack both Nanog and Nodal activity points to the existence of another factor that protects these cells from differentiation. We propose that this factor is Id1.
Recent findings indicate that extraembryonic endoderm potency is not irreversibly lost but rather remains latent in epiblast cells during implantation (Nowotschin et al., 2019) . This implies the existence of mechanisms that protect the epiblast from differentiating into extraembryonic endoderm throughout the course of pregastrulation development. Nanog performs this role in the E3.5 embryo (Mitsui et al., 2003) , and we now propose that Id1 takes over this role immediately after downregulation of Nanog. In support of this idea, we find that Id1 can protect Nanog-null cells from differentiating into primitive endoderm.
BMP Maintains Epiblast Identity Specifically during the Transition between Naive and Primed States
Id1 is a target of BMP signaling (Hollnagel et al., 1999 ) that contributes to maintenance of pluripotency in ESCs cultured in LIF + BMP4 or LIF + FCS . It has been proposed that Id1 maintains Nanog expression (Galvin-Burgess et al., 2013; Romero-Lanman et al., 2012) , but this seems inconsistent with the observation that Id1 is not co-expressed with Nanog in vitro or in vivo. We reconcile our findings with these reports by proposing that Id1 does not directly maintain Nanog expression, but rather increases the probability that Nanog-low cells will return to a Nanog-high state.
Our findings also explain the previously puzzling observation that BMP is required for maintaining pluripotency in ESCs cultured as a mixture of naive and primed states in LIF + FCS Zhang et al., 2010) yet is not required for maintaining pluripotency in homogenous populations of naive cells (Graham et al., 2014; Morikawa et al., 2016; Zhao, 2003) nor primed cells (Brons et al., 2007; Tesar et al., 2007) . Our model is also consistent with the observation that BMP is not required for pre-implantation development (Graham et al., 2014; Zhao, 2003) but is required to maintain pluripotency subsequently (Di-Gregorio et al., 2007) .
Much is known about the transcriptional regulators required to escape naive pluripotency and establish a primed state (Betschinger et al., 2013; Buecker et al., 2014; Galonska et al., 2015; Leeb et al., 2014; Yang et al., 2012) . For instance, the FGF target gene Egr1 drives reorganization of enhancer binding as cells proceed to a primed state (Galonska et al., 2015; Kumar and Ivanova, 2015) . Our data place Id1 upstream of these factors, operating to suppress Egr1 and thus help to transiently stabilize the naive state in the absence of Nanog. We cannot, however, exclude the possibility that factors other than Egr1 also act downstream of Id1.
Id1 Confers Robustness to Early Development
Id1-null embryos progress through early development (Lyden et al., 1999) , and Id1-null cells can differentiate in vitro (Romero-Lanman et al., 2012) , so it is clear that Id1 is not absolutely required for early developmental transitions. Rather, we propose that Id1 makes early development more robust by shielding epiblast cells from pro-differentiation cues and ensuring that cells exit naive pluripotency only once signals to sustain the primed state are present. We confirm that Id1-null cells can proceed through early development in chimeric embryos but do so less robustly than their wild-type neighbors.
In summary, we propose that Id1 protects epiblast identity specifically during the transition from naive to primed states. As embryos progress through implantation, a build-up of Nodal simultaneously provides the environment that supports a primed epiblast state and suppresses expression of Id1 to permit the transition to this state. Our findings support the idea that in order for changes in cell fate to occur at the correct time and place, mechanisms must exist to ensure that differentiation is coordinated with changes in responsiveness to extrinsic cues. Such mechanisms ensure canalization during early development (Waddington, 1959) and also help to explain why it is not straightforward to control differentiation of pluripotent cells in vitro simply by controlling exposure to extrinsic signals.
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